Clinical Trials for Atypical Hemolytic Uremic Syndrome

Find clinical trials for atypical hemolytic uremic syndrome. Discover research opportunities and treatment options in your area.

8 Active Trials Found

Showing 8 trials on this page

Page 1 of 1

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

NCT ID: NCT01793168

The Coordination of Rare Diseases at Sanford (CoRDS) is a clinical trial aimed at creating a large, centralized registry for individuals affected by rare diseases. This registry helps connect patie...

Recruiting

Type: observational Locations: Sioux Falls, South Dakota, United States, Sydney, , Australia

Developing a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare Diseases

NCT ID: NCT05996731

This clinical trial is focused on using a new technology called RNA sequencing (RNA-Seq) to help diagnose rare genetic diseases in patients of all ages, including children. The goal is to identify ...

Recruiting

Phase: NA Type: interventional Locations: Ranica, Bg, Italy

Functional Implications of Rare Gene Mutations in aHUS Open the Door to Personalized Therapy

NCT ID: NCT05805202

This clinical trial is studying a rare condition called atypical Hemolytic Uremic Syndrome (aHUS), which affects how blood cells and small blood vessels function, often leading to kidney problems. ...

Recruiting

Phase: NA Type: interventional Locations: Ranica, Bg, Italy

Evaluate Long-term Safety, Tolerability and Efficacy of Iptacopan in Study Participants With aHUS

NCT ID: NCT05795140

This clinical trial is studying the long-term effects of a medication called iptacopan in people with a condition known as atypical Hemolytic Uremic Syndrome (aHUS). The goal is to see how safe the...

Recruiting

Phase: PHASE3 Type: interventional Locations: Sao Paulo, Sp, Brazil, Beijing, , China +3 more

Efficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With Atypical Hemolytic Uremic Syndrome (aHUS)

NCT ID: NCT05935215

This clinical trial is studying a new treatment called iptacopan for patients with a rare condition known as atypical hemolytic uremic syndrome (aHUS). The goal is to see if switching from their cu...

Recruiting

Phase: PHASE3 Type: interventional Locations: Cordoba, Andalucia, Spain, Nanjing, Jiangsu, China +12 more

Efficacy and Safety of Iptacopan (LNP023) in Adult Patients With Atypical Hemolytic Uremic Syndrome Naive to Complement Inhibitor Therapy

NCT ID: NCT04889430

This clinical trial is studying a new treatment called iptacopan (also known as LNP023) for adults with a condition called atypical hemolytic uremic syndrome (aHUS). This study aims to find out if ...

Recruiting

Phase: PHASE3 Type: interventional Locations: Minneapolis, Minnesota, United States, Durham, North Carolina, United States +93 more

National Registry of Rare Kidney Diseases

NCT ID: NCT06065852

The National Registry of Rare Kidney Diseases is a research project aimed at gathering information from patients who have specific rare kidney diseases. By collecting this data, the researchers hop...

Recruiting

Type: observational Locations: Bristol, South West, United Kingdom

Safety and Efficacy Study of OMS721 in Patients With Atypical Hemolytic Uremic Syndrome

NCT ID: NCT03205995

This clinical trial is testing a new treatment called OMS721 for patients with atypical hemolytic uremic syndrome (aHUS), a rare condition that can affect the blood and kidneys. The main goals of t...

Recruiting

Phase: PHASE3 Type: interventional Locations: Los Angeles, California, United States, Chicago, Illinois, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions